As of 2026-08-24, Eledon Pharmaceuticals, Inc. Common Stock (ELDN) has a 3-month relative strength percentile of 27 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 1.20×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ELDN is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 20 ETFs · $19M across latest filings · largest weight 0.03% (IWC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $13K |
| — |
| URTY | 0.00% | $11K | — |
| UWM | 0.00% | $10K | — |
| HDG | 0.00% | $267 | — |
| RB | 0.01% | $80 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELDN Jan avg: 24.98% median: 27.66% win: 75% σ: 24.28% n: 4 2022-04-12 → 2026-07-31 | ELDN Feb avg: -4.22% median: -3.53% win: 50% σ: 19.98% n: 4 2022-04-12 → 2026-07-31 | ELDN Mar avg: 3.42% median: 7.22% win: 75% σ: 16.38% n: 4 2022-04-12 → 2026-07-31 | ELDN Apr avg: 1.44% median: -6.78% win: 40% σ: 14.39% n: 5 2022-04-12 → 2026-07-31 | ELDN May avg: 3.78% median: 4.25% win: 80% σ: 7.43% n: 5 2022-04-12 → 2026-07-31 | ELDN Jun avg: -13.71% median: -9.67% win: 20% σ: 15.35% n: 5 2022-04-12 → 2026-07-31 | ELDN Jul avg: 7.50% median: 11.36% win: 80% σ: 14.66% n: 5 2022-04-12 → 2026-07-31 | ELDN Aug avg: 3.13% median: 2.86% win: 50% σ: 18.29% n: 4 2022-04-12 → 2026-07-31 (current) | ELDN Sep avg: -11.91% median: -10.63% win: 0% σ: 10.90% n: 4 2022-04-12 → 2026-07-31 | ELDN Oct avg: 38.68% median: 40.33% win: 75% σ: 46.02% n: 4 2022-04-12 → 2026-07-31 | ELDN Nov avg: -21.77% median: -13.03% win: 50% σ: 29.85% n: 4 2022-04-12 → 2026-07-31 | ELDN Dec avg: 7.75% median: -6.96% win: 25% σ: 32.59% n: 4 2022-04-12 → 2026-07-31 |